Jonathan Mitchell - Concepedia

Author

Jonathan Mitchell

Johns Hopkins University ORCID

Also Known As

J Mitchell, J. Mitchell, Jonathan D. Mitchell, Jonathan Mitchell, Mitchell, Jonathan D.

Publications

933

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine University of Wisconsin–Madison Nambour General Hospital Westmead Institute for Medical Research

About

Jonathan Mitchell is an author at Johns Hopkins University specializing in immunotherapy, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	92
2	Immunology	3	3	92
3	Hepatology	1	1	52
4	Pharmacology	1	1	52
5	Autoimmune Liver Disease	1	1	52

Jonathan Mitchell

Publications

771

Citations

H-Index

Page 1

	Year	Citations
Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease Harry R. Dalton, William Stableforth, Prem Harichander Thurairajah, European Journal of Gastroenterology & Hepatology	2008	284
Autochthonous hepatitis E in southwest England Harry R. Dalton, Prem Harichander Thurairajah, H. J. Fellows, Journal of Viral Hepatitis	2006	156
The hepatopulmonary syndrome: radiologic findings in 10 patients. H. Page McAdams, Jeremy Erasmus, Rowena Crockett, American Journal of Roentgenology	1996	114
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy Stuart K. Roberts, Ricky Lim, Simone I. Strasser, Clinical Gastroenterology and Hepatology Mycophenolate MofetilHepatologyViral HepatitisMedicineImmunosuppressive Therapy	2017	52
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels Amanda Nicoll, Stuart K. Roberts, Ricky Lim, Alimentary Pharmacology & Therapeutics	2019	36
Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients Andrew H. Karaba, Jake D. Kim, Teresa Po‐Yu Chiang, Solid Organ TransplantationTransplantation MedicineImmunologyOmicron Ba.1Immunotherapy	2022	21
Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients Jennifer L. Alejo, Jonathan Mitchell, Teresa Po‐Yu Chiang, Transplantation VaccinationTransplantationVaccine DevelopmentImmunologyTherapeutic Vaccine	2021	19
Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination Teresa Po‐Yu Chiang, Jennifer L. Alejo, Jonathan Mitchell, American Journal of Transplantation	2022	19
Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients Jonathan Mitchell, Caoilfhionn M Connolly, Teresa Po‐Yu Chiang, JAMA Network Open	2022	17
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation Jennifer L. Alejo, Jonathan Mitchell, Teresa Po‐Yu Chiang, Transplantation	2022	17

Page 1